Telemedicine company FemGevity, a trailblazer in women’s health and longevity, is hosting a free webinar on March 27 with Womaness that will feature a comprehensive discussion with medical professionals on gut health, weight loss genomics, sexual health, and hormone replacement therapy.
The panelists include FemGevity co-founder Kristin Mallon, a board-certified nurse midwife and expert on menopause, feminine longevity and breast health; Beth Traflet, APRN, a NYU-trained women’s health nurse practitioner specializing in menopause and longevity medicine; and Melissa Ferrara, a family nurse practioner specializing in women’s health and female sexual dysfunction. Ferrara is also the associate medical director at Maze Women’s Health.
Along with event hosts Michelle Jacobs and FemGevity co-founder and CEO Michele Wispelwey, the panel will delve into the intricacies of holistic wellness, the pros and cons of hormone replacement therapy (HRT), sexual wellness, and the challenges of weight gain. Go here to register for this live event at 12:30 p.m. on Wednesday, March 27.
NJBIA member FemGevity, headquartered in Hoboken, provides innovative menopause treatments and longevity medicine through telemedicine and at-home lab services in New Jersey. FemGevity provides women with precision medicine to reach their peak health with board-certified medical providers who craft individualized, tailor-made laboratory assessments and treatment plans that resonate with each patient’s distinctive physical, mental, and social needs.
In addition, FemGevity offers menopause workplace solutions and point-of-care products explicitly designed to address the needs of working women while also providing substantial value to employers.
To learn more about FemGevity, go to their website at www.femgevityhealth.com or text (212) 301-7776 to book a free consultation to learn more.
